TY - JOUR
T1 - Voltage-dependent N-type Ca2+ channels in endothelial cells contribute to oxidative stress-related endothelial dysfunction induced by angiotensin II in mice
AU - Nishida, Motohiro
AU - Ishikawa, Tatsuya
AU - Saiki, Shota
AU - Sunggip, Caroline
AU - Aritomi, Shizuka
AU - Harada, Eri
AU - Kuwahara, Koichiro
AU - Hirano, Katsuya
AU - Mori, Yasuo
AU - Kim-Mitsuyama, Shokei
N1 - Funding Information:
M. N. and T. I. designed and analyzed the experiments and wrote the paper. S. S., C. S., S. A., and E. H. performed animal study, and analyze the study. K. K., H. K., and Y. M. helped design and edited the paper. K-M. S. decided to submit the article. This work was supported by a Grant-in-Aid for Ajinomoto Pharmaceuticals Co., Inc. (to M. N.), by the Uehara Memorial Foundation (to M. N., K. K., and Y. M.), and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to M. N.). The authors declare no conflict of interest.
PY - 2013/5/3
Y1 - 2013/5/3
N2 - N-type voltage-dependent Ca2+channels (VDCCs), expressed predominantly in the nervous system, play pivotal roles in sympathetic regulation of the circulatory system. Although N-type VDCCs are also reportedly expressed in the vasculature, their pathophysiological role is obscure. We demonstrated that oxidative stress-related endothelial dysfunction induced by angiotensin (Ang) II is suppressed in mice lacking the N-type VDCC α1B subunit (Cav 2.2). Impairment of endothelium-dependent relaxation of the thoracic aorta observed following Ang II treatment in wild-type (WT) mice was significantly attenuated in the Ang II-treated Cav 2.2-deficient mice, despite the comparable increase of the blood pressure in the two groups of mice. The thoracic aorta of the Cav 2.2-deficient mice showed a smaller positive area of oxidative stress markers as compared to the WT mice. The Ang II-induced endothelial dysfunction was also suppressed by cilnidipine, an L/N-type VDCC blocker, but not by amlodipine, an L-type VDCC blocker; however, this unique effect of cilnidipine was completely abolished in the Cav 2.2-deficient mice. Furthermore, selective inhibition of N-type VDCCs by ω-conotoxin GVIA dramatically suppressed the production of reactive oxygen species (ROS) as well as agonist-induced Ca2+ influx in the vascular endothelial cells. These results suggest that N-type VDCCs expressed in the vascular endothelial cells contribute to ROS production and endothelial dysfunction observed in Ang II-treated hypertensive mice.
AB - N-type voltage-dependent Ca2+channels (VDCCs), expressed predominantly in the nervous system, play pivotal roles in sympathetic regulation of the circulatory system. Although N-type VDCCs are also reportedly expressed in the vasculature, their pathophysiological role is obscure. We demonstrated that oxidative stress-related endothelial dysfunction induced by angiotensin (Ang) II is suppressed in mice lacking the N-type VDCC α1B subunit (Cav 2.2). Impairment of endothelium-dependent relaxation of the thoracic aorta observed following Ang II treatment in wild-type (WT) mice was significantly attenuated in the Ang II-treated Cav 2.2-deficient mice, despite the comparable increase of the blood pressure in the two groups of mice. The thoracic aorta of the Cav 2.2-deficient mice showed a smaller positive area of oxidative stress markers as compared to the WT mice. The Ang II-induced endothelial dysfunction was also suppressed by cilnidipine, an L/N-type VDCC blocker, but not by amlodipine, an L-type VDCC blocker; however, this unique effect of cilnidipine was completely abolished in the Cav 2.2-deficient mice. Furthermore, selective inhibition of N-type VDCCs by ω-conotoxin GVIA dramatically suppressed the production of reactive oxygen species (ROS) as well as agonist-induced Ca2+ influx in the vascular endothelial cells. These results suggest that N-type VDCCs expressed in the vascular endothelial cells contribute to ROS production and endothelial dysfunction observed in Ang II-treated hypertensive mice.
UR - http://www.scopus.com/inward/record.url?scp=84877050789&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84877050789&partnerID=8YFLogxK
U2 - 10.1016/j.bbrc.2013.03.040
DO - 10.1016/j.bbrc.2013.03.040
M3 - Article
C2 - 23537646
AN - SCOPUS:84877050789
SN - 0006-291X
VL - 434
SP - 210
EP - 216
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 2
ER -